We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 20

Privacy & cybersecurity update, issue 3 - October, 2014

  • Jones Day
  • -
  • Australia, Brazil, Canada, Chile, China, European Union, France, Germany, Hong Kong, Ireland, Italy, Japan, Mexico, Netherlands, New Zealand, Russia, Taiwan, USA
  • -
  • October 15 2014

On August 1, the Federal Trade Commission ("FTC") issued a report on mobile shopping applications. In it, the FTC found that such apps often fail to

GlaxoSmithKline and five executives convicted of bribery in China

  • Fenwick & West LLP
  • -
  • China, USA
  • -
  • September 24 2014

On Friday, September 19, 2014, a Chinese court found pharmaceutical giant GlaxoSmithKline guilty of bribing doctors and hospitals in order to

GSK China fined a record $492 million for bribery in China

  • Herbert Smith Freehills LLP
  • -
  • China
  • -
  • September 22 2014

In a landmark case, a Chinese court has fined GlaxoSmithKline's China subsidiary (GSK China) US$ 492 million dollars for bribing doctors and

Food, dietary supplement & cosmetics regulatory update, Issue 11

  • Jones Day
  • -
  • Canada, China, USA
  • -
  • August 8 2014

Last week, a divided federal appeals court ruled that FDA cannot be forced to ban antibiotics in food-producing healthy livestock. Thedecision comes

Patent protection for medical uses and relevant judicial practice in China

  • Wan Hui Da Intellectual Property Agency
  • -
  • China
  • -
  • June 18 2014

The Supreme People's Court (hereinafter refers to as SPC) recently announced "2013 Top Ten Innovative Intellectual Property Cases of Chinese Court"

Lilly scientists prosecuted for trade secret theft

  • Fish & Richardson PC
  • -
  • China, USA
  • -
  • October 17 2013

Two former Eli Lilly scientists were arrested and charged by the U.S. Government for stealing and transmitting Lilly trade secrets to a Chinese

China’s Patent Re-Examination Board says pharmaceutical salts not patentable over pure compounds

  • Greenberg Traurig LLP
  • -
  • China
  • -
  • August 14 2013

In July 2013, the Patent Re-Examination Board of China's State Intellectual Property Office invalidated the U.S. biotech company, Gilead Sciences'

China newsletter - summer 2013

  • Greenberg Traurig LLP
  • -
  • China, Macau
  • -
  • July 17 2013

For the purpose of fully implementing the spirit of the Eighteenth National Congress of the Communist Party of China and attracting more foreign

Life sciences: 2013 legal developments you need to know about

  • Mayer Brown LLP
  • -
  • China, European Union, France, USA
  • -
  • July 16 2013

This is a short guide outlining some of the key legal developments in the life sciences sector in 2013. The developments include the Supreme Court

Changing trends in patent protection for the pharma industry

  • Heskia - Hacmun Law Firm
  • -
  • China, India, Israel
  • -
  • June 6 2013

This April India's Supreme Court oversaw a high profile case involving Novartis' patent application for Glivec, a cancer-battling medication